392 related articles for article (PubMed ID: 23475719)
1. Assessing Fc glycan heterogeneity of therapeutic recombinant monoclonal antibodies using NP-HPLC.
Raju TS
Methods Mol Biol; 2013; 988():169-80. PubMed ID: 23475719
[TBL] [Abstract][Full Text] [Related]
2. Control of recombinant monoclonal antibody effector functions by Fc N-glycan remodeling in vitro.
Hodoniczky J; Zheng YZ; James DC
Biotechnol Prog; 2005; 21(6):1644-52. PubMed ID: 16321047
[TBL] [Abstract][Full Text] [Related]
3. Comparison of methods for the analysis of therapeutic immunoglobulin G Fc-glycosylation profiles-Part 2: Mass spectrometric methods.
Reusch D; Haberger M; Falck D; Peter B; Maier B; Gassner J; Hook M; Wagner K; Bonnington L; Bulau P; Wuhrer M
MAbs; 2015; 7(4):732-42. PubMed ID: 25996192
[TBL] [Abstract][Full Text] [Related]
4. In vitro galactosylation of human IgG at 1 kg scale using recombinant galactosyltransferase.
Warnock D; Bai X; Autote K; Gonzales J; Kinealy K; Yan B; Qian J; Stevenson T; Zopf D; Bayer RJ
Biotechnol Bioeng; 2005 Dec; 92(7):831-42. PubMed ID: 16187338
[TBL] [Abstract][Full Text] [Related]
5. Cetuximab Fab and Fc N-glycan fast characterization using IdeS digestion and liquid chromatography coupled to electrospray ionization mass spectrometry.
Janin-Bussat MC; Tonini L; Huillet C; Colas O; Klinguer-Hamour C; Corvaïa N; Beck A
Methods Mol Biol; 2013; 988():93-113. PubMed ID: 23475716
[TBL] [Abstract][Full Text] [Related]
6. Metabolic control of recombinant monoclonal antibody N-glycosylation in GS-NS0 cells.
Hills AE; Patel A; Boyd P; James DC
Biotechnol Bioeng; 2001 Oct; 75(2):239-51. PubMed ID: 11536148
[TBL] [Abstract][Full Text] [Related]
7. Higher levels of sialylated Fc glycans in immunoglobulin G molecules can adversely impact functionality.
Scallon BJ; Tam SH; McCarthy SG; Cai AN; Raju TS
Mol Immunol; 2007 Mar; 44(7):1524-34. PubMed ID: 17045339
[TBL] [Abstract][Full Text] [Related]
8. Chemical and enzymatic N-glycan release comparison for N-glycan profiling of monoclonal antibodies expressed in plants.
Triguero A; Cabrera G; Royle L; Harvey DJ; Rudd PM; Dwek RA; Bardor M; Lerouge P; Cremata JA
Anal Biochem; 2010 May; 400(2):173-83. PubMed ID: 20109437
[TBL] [Abstract][Full Text] [Related]
9. N-glycans of recombinant human acid alpha-glucosidase expressed in the milk of transgenic rabbits.
Jongen SP; Gerwig GJ; Leeflang BR; Koles K; Mannesse ML; van Berkel PH; Pieper FR; Kroos MA; Reuser AJ; Zhou Q; Jin X; Zhang K; Edmunds T; Kamerling JP
Glycobiology; 2007 Jun; 17(6):600-19. PubMed ID: 17293352
[TBL] [Abstract][Full Text] [Related]
10. Comparison of methods for the analysis of therapeutic immunoglobulin G Fc-glycosylation profiles--part 1: separation-based methods.
Reusch D; Haberger M; Maier B; Maier M; Kloseck R; Zimmermann B; Hook M; Szabo Z; Tep S; Wegstein J; Alt N; Bulau P; Wuhrer M
MAbs; 2015; 7(1):167-79. PubMed ID: 25524468
[TBL] [Abstract][Full Text] [Related]
11. The criticality of high-resolution N-linked carbohydrate assays and detailed characterization of antibody effector function in the context of biosimilar development.
Brady LJ; Velayudhan J; Visone DB; Daugherty KC; Bartron JL; Coon M; Cornwall C; Hinckley PJ; Connell-Crowley L
MAbs; 2015; 7(3):562-70. PubMed ID: 25898160
[TBL] [Abstract][Full Text] [Related]
12. Quantitative glycan profiling of normal human plasma derived immunoglobulin and its fragments Fab and Fc.
Anumula KR
J Immunol Methods; 2012 Aug; 382(1-2):167-76. PubMed ID: 22683540
[TBL] [Abstract][Full Text] [Related]
13. Restricted processing of CD16a/Fc γ receptor IIIa
Patel KR; Roberts JT; Subedi GP; Barb AW
J Biol Chem; 2018 Mar; 293(10):3477-3489. PubMed ID: 29330305
[TBL] [Abstract][Full Text] [Related]
14. High-mannose glycans on the Fc region of therapeutic IgG antibodies increase serum clearance in humans.
Goetze AM; Liu YD; Zhang Z; Shah B; Lee E; Bondarenko PV; Flynn GC
Glycobiology; 2011 Jul; 21(7):949-59. PubMed ID: 21421994
[TBL] [Abstract][Full Text] [Related]
15. Mass spectrometry and HPLC for carbohydrate analysis.
Siemiiatkoski J; Lyubarskaya Y
Dev Biol (Basel); 2005; 122():69-74. PubMed ID: 16375251
[TBL] [Abstract][Full Text] [Related]
16. Contrasting glycosylation profiles between Fab and Fc of a human IgG protein studied by electrospray ionization mass spectrometry.
Mimura Y; Ashton PR; Takahashi N; Harvey DJ; Jefferis R
J Immunol Methods; 2007 Sep; 326(1-2):116-26. PubMed ID: 17714731
[TBL] [Abstract][Full Text] [Related]
17. The effect of Fc glycan forms on human IgG2 antibody clearance in humans.
Chen X; Liu YD; Flynn GC
Glycobiology; 2009 Mar; 19(3):240-9. PubMed ID: 18974198
[TBL] [Abstract][Full Text] [Related]
18. Antibody glycosylation and its impact on the pharmacokinetics and pharmacodynamics of monoclonal antibodies and Fc-fusion proteins.
Liu L
J Pharm Sci; 2015 Jun; 104(6):1866-1884. PubMed ID: 25872915
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic antibody glycosylation analysis: a contract research organization perspective in the frame of batch release or comparability support.
Delobel A; Cantais F; Catrain A; Dereux E; Van Vyncht G
Methods Mol Biol; 2013; 988():115-43. PubMed ID: 23475717
[TBL] [Abstract][Full Text] [Related]
20. N- and O-glycans of recombinant human C1 inhibitor expressed in the milk of transgenic rabbits.
Koles K; van Berkel PH; Pieper FR; Nuijens JH; Mannesse ML; Vliegenthart JF; Kamerling JP
Glycobiology; 2004 Jan; 14(1):51-64. PubMed ID: 14514717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]